期刊文献+

红花总黄素对糖尿病大鼠血管内皮功能的保护作用 被引量:7

Influence of Safflower Yellow on Vascular Endothelial Function of Rats with Diabetes
下载PDF
导出
摘要 目的观察红花总黄素对糖尿病大鼠血管内皮功能失调的影响。方法雌性SD大鼠分为4组,每组10只:对照组,模型组,红花总黄素低、高剂量组。一次性腹腔注射STZ诱发大鼠糖尿病模型,测定各组大鼠体质量、空腹血糖、血清NO、ET、CGRP水平和胸主动脉舒张功能。结果比较模型组,红花总黄素组大鼠体质量和血糖无明显差异(P>0.05),血清NO、CGRP水平明显升高(P<0.05),血清ET水平则明显下降(P<0.05或P<0.01),胸主动脉对(10-7~10-5)mol/L累积剂量ACh的舒张反应百分率明显提高(P<0.05或P<0.01)。结论红花总黄素可保护糖尿病大鼠血管内皮功能。 Objective To observe the intervention effect of safflower yellow (SY) on vascular endothelial dysfunction of rats with diabetes. Methods A total of 40 female SD rats were divided into 4 groups with 10 in each group. The d groups were as follows:control group, model group, low dose SY group, and high dose SY group. Streptozocin (STZ) given by intraperitoneal injection was used to induce diabetes model in rats. The influence of SY on body weight, fasting glucose, serum NO, serum ET and diastolic function in thoracic aortas was observed in rats with diabetes. Results Compared with model group, the body weight and glucose was not significantly different with those in SY group ( P 〉 0. 05 ), while the level of serum NO and CGRP significantly increased ( P 〈 0.05 ), and the level of serum ET obviously decreased ( P 〈 0.05 or P 〈0.01 ). The diastolic response percentage of thoracic aortas to Ach with accumulated dose of( 10-7 -10-5) mol/L obviously increased(P 〈0.05 or P 〈0.01 ). Conclusion SY has protective effect on vascular endothelial function in rats with diabetes.
出处 《今日药学》 CAS 2013年第4期220-222,共3页 Pharmacy Today
关键词 红花总黄素 糖尿病 大鼠 血管内皮功能 safflower yellow diabetes rat vascular endothelial function
  • 相关文献

参考文献5

二级参考文献30

  • 1汤习锋,康格非,曾成鸣.高效液相色谱分析生物膜磷脂[J].生物化学与生物物理进展,1993,20(5):399-401. 被引量:19
  • 2岳增辉,严洁,常小荣.高脂血症与血管内皮细胞及其黏附分子的相关研究进展[J].中西医结合心脑血管病杂志,2005,3(2):149-150. 被引量:6
  • 3陈思锋,吴中立.体液和组织磷脂酶A_2简便快速测定法[J].第二军医大学学报,1989,10(3):254-256. 被引量:210
  • 4谢宇光,石雪颖,于晓玲.血脂异常与血管内皮细胞损伤对动脉粥样硬化形成的协同作用[J].中国心血管病研究,2006,4(6):478-480. 被引量:14
  • 5Krentz AJ,Bailey CJ.Oral antidiabetic agents:current role in type 2diabetes mellitus.Drugs,2005,65(3):385-411.
  • 6Pereira AM,Biermasz NR,Roelfsema F,et al.A pharmacologic therapies for acromegaly:a review of their effects on glucose metabolism and insulin resistance.Treatments Endocrinol,2005,4(1):43-53.
  • 7Tenenbaum A,Motro M,Fisman EZ,et al.Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.Circulation,2004,109(18):2197-2202.
  • 8Bergman RN.Non-esterified fatty acids and the liver.Why is insulin secreted into the portal vein? Diabetologia,2000,43:946-952.
  • 9Unger RH.Lipotoxic diseases.Annu Rev Med,2002,53:319-336.
  • 10Talpur N,Echard B,Ingram C,et al.Effects of a novel formulation of essential oils on glucose-insulin metabolism in diabetic and hypertensive rats:a pilot study.Diabetes Obes Metab,2005,7(2):193-199.

共引文献60

同被引文献139

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部